Selected publications shaping psychopharmacology as a discipline

Author

EF. Domino

Year of publication

2002

Not available

The third volume of Pharmacology Revisited: an Esteve Foundation Series gathers 33 articles related to psychopharmacology. In Selected publications shaping psychopharmacology as a discipline, professor Edward F. Domino, from the Department of Pharmacology of the University of Michigan, compiled the most relevant texts in this field published in journals like The Lancet, Pharmacology & Toxicology or The Medical Journal of Australia. As is usual in this Esteve Foundation’s series, a facsimile edition of these articles is provided.

Full document
Full PDF	EF. Domino	[wpdm type=”btn3″]
Chapters
Acknowledgements		[wpdm id=23 type=”btn”]
Introduction	EF. Domino	[wpdm id=21 type=”btn”]
Reference list		[wpdm id=22 type=”btn”]
Index		[wpdm id=20 type=”btn”]
1. Un nouveau stabilisateur végétatif (LE 4560 RP)	H. Laborit / P. Huguenard / R. Allaume	[wpdm type=”btn3″]
2. Utilisation en thérapeutique psychiatrique d\’une phénothiazine d\’action centrale élective (4560 RP)	J. Delay / P. Deniker / JM. Harl	[wpdm type=”btn3″]
3. Propriétés pharmacodynamiques du chlorhydrate de chloro-3 (diméthylamino-3\’ propyl)-10 phénothiazine (4.560 R.P.)	S. Courvoisier / J. Fournel / R. Ducrot / M. Kolsky / P. Koetschet	[wpdm type=”btn3″]
4. A controlled clinical test of a new psycholeptic drug (haloperidol)	E. Brandrup / P. Kristjansen	[wpdm type=”btn3″]
5. The butyrophenone story	PAJ. Janssen	[wpdm type=”btn3″]
6. Antipsychotic drug doses and neuroleptic/dopamine receptors	P. Seeman / T. Lee / M. Chau-Wong / K. Wong	[wpdm type=”btn3″]
7. The current status of the dopamine hypothesis of schizophrenia	A. Carlsson	[wpdm type=”btn3″]
8. Comments and reply on \”The current status of the dopamine hypothesis of schizophrenia\”	DF. Klein / AJ. Friedhoff / HY. Meltzer / SH. Snyder / A. Carlsson	[wpdm type=”btn3″]
9. Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine	J. Kane / G. Honigfeld / J. Singer / H. Meltzer / Clozaril Collaborative Study Group	[wpdm type=”btn3″]
10. Clinical studies on the mechanism of action of clozapine: The dopamine-serotonin hypothesis of schizophrenia	HY. Meltzer	[wpdm type=”btn3″]
11. Iproniazid (Marsilid®) phosphate, a therapeutic agent for mental disorders and debilitating diseases	GE. Crane	[wpdm type=”btn3″]
12. The treatment of depressive states with G 22355 (imipramine hydrochloride)	R. Kuhn	[wpdm type=”btn3″]
13. A concept for a role of serotonin and norepinephrine as chemical mediators in the brain	BB. Brodie / PA. Shore	[wpdm type=”btn3″]
14. Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect	IP. Lapin / GF. Oxenkrug	[wpdm type=”btn3″]
15. Initial clinical trial based on biochemical methodology of zimelidine (a serotonin uptake inhibitor) in depressed patients	B. Siwers / VA. Ringberger / JR. Tuck / F. Sjöqvist	[wpdm type=”btn3″]
16. A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3-(p-trifluoromethylphenoxy)-N-ethyl-3-phenylpropylamine	DT. Wong / FP. Bymaster / JS. Horng / BB. Molloy	[wpdm type=”btn3″]
17. The psychosedative properties of methaminodiazepoxide	LO. Randall / GAH. Schallek / EF. Keith / RE. Bagdon	[wpdm type=”btn3″]
18. Tolerance development with chlordiazepoxide in relation to the plasma levels of the parent compound and its main metabolites in mice	JD. Christensen	[wpdm type=”btn3″]
19. Selective antagonists of benzodiazepines	W. Hunkeler / H. Möhler / L. Pieri / P. Polc / EP. Bonetti / R. Cumin / R. Schaffner / W. Haefely	[wpdm type=”btn3″]
20. New concepts on the mechanism of action of benzodiazepines	E. Costa / A. Guidotti / CC. Mao / A. Suria	[wpdm type=”btn3″]
21. Lithium salts in the treatment of psychotic excitement	JFJ. Cade	[wpdm type=”btn3″]
22. The treatment of manic psychoses by the administration of lithium salts	M. Schou / N. Juel-Nielsen / E. Strömgren / H. Voldby	[wpdm type=”btn3″]
23. Lithium as a prophylactic agent: Its effect against recurrent depressions and manic-depressive psychosis	PC. Baastrup / M. Schou	[wpdm type=”btn3″]
24. N-allyl-norcodeine and N-allyl-normorphine, two antagonists to morphine	ER. Hart	[wpdm type=”btn3″]
25. A medical treatment for diacetylmorphine (heroin) addiction: A clinical trial with methadone hydrochloride	VP. Dole / M. Nyswander	[wpdm type=”btn3″]
26. Stereospecific and nonspecific interactions of the morphine congener levorphanol in subcellular fractions of mouse brain	A. Goldstein / LI. Lowney / BK. Pal	[wpdm type=”btn3″]
27. Opiate receptor: Demonstration in nervous tissue	CB. Pert / SH. Snyder	[wpdm type=”btn3″]
28. Identification of two related pentapeptides from the brain with potent opiate agonist activity	J. Hughes / TW. Smith / HW. Kosterlitz / LA. Fothergill / BA. Morgan / HR. Morris	[wpdm type=”btn3″]
29. Determination and characterization of a cannabinoid receptor in rat brain	WA. Devane / FA. Dysarz III / M. Ross Johnson / LS. Melvin / AC. Howlett	[wpdm type=”btn3″]
30. Psychotomimetic drugs: Chemical and pharmacological aspects	A. Hofmann	[wpdm type=”btn3″]
31. Study of a new schizophrenomimetic drug – Sernyl	ED. Luby / BD. Cohen / G. Rosenbaum / JS. Gottlieb / R. Kelley	[wpdm type=”btn3″]
32. Pharmacologic effects of CI-581, a new dissociative anesthetic, in man	EF. Domino / P. Chodoff / G. Corssen	[wpdm type=”btn3″]
33. Dynamics of drug dependence: Implications of a conditioning theory for research and treatment	A. Wikler	[wpdm type=”btn3″]
34. Self-administration of psychoactive substances by the monkey: A measure of psychological dependence	G. Deneau / T. Yanagita / MH. Seevers	[wpdm type=”btn3″]

Selected publications shaping psychopharmacology as a discipline Index
Download

Selected publications shaping psychopharmacology as a discipline Acknowledgements
Download

Selected publications shaping psychopharmacology as a discipline Introduction
EF. Domino
Download

Selected publications shaping psychopharmacology as a discipline Reference list
Download